Min Wang

6PUBLICATIONS

25CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 06, 2026

Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China.

|May 30, 2026

Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer.

|Jan 29, 2026

Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3.

Yongkang Shi, Jun Gong, Lin Chen

|Oct 16, 2025

The multifaceted roles of deubiquitinating enzymes (DUBs) in pancreatic ductal adenocarcinoma.

Min Zhou, Rongtian Wei, Jianwei Zhang

|Nov 13, 2024

Clinical functional proteomics of intercellular signalling in pancreatic cancer.

Peiwu Huang, Weina Gao, Changying Fu

|Jul 29, 2022

A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.

Chunle Zhao, Jun Gong, Yu Bai

Pageof 1

Frequent Collaborators

Renyi Qin

Jun Gong

Chunle Zhao

Shutao Pan

Ruijun Tian

Hang Zhang

Peiwu Huang

Dong Gao

Tony Hunter

Yongkang Shi

Frequent Collaborators

Renyi Qin

Jun Gong

Chunle Zhao

Shutao Pan